Publication | Closed Access

Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-α2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study

Urological ResearchUrologySurgical OncologyUrologic Cancer EpidemiologyGenitourinary CancerCalmette-guérin Is SuperiorMedicineNordic StudyOncologyRadiation OncologyCancer ResearchIntravesical Treatment